Compounds > 3,4-dihydroxyphenylacetic acid
Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Kidney Diseases

3,4-dihydroxyphenylacetic acid has been researched along with Kidney Diseases in 2 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soares-da-Silva, P2
Pestana, M2
Ferreira, A1
Damasceno, A1
Polónia, J1
Cerqueira-Gomes, M1
Jardim, H1
Correia, F1
Vieira-Coelho, MA1

Reviews

2 reviews available for 3,4-dihydroxyphenylacetic acid and Kidney Diseases

ArticleYear
Renal dopaminergic mechanisms in renal parenchymal diseases, hypertension, and heart failure.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2000, Volume: 22, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Heart Failure; Hemodynamics; Humans; Hypertension

2000
Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16 Suppl 1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blood Pressure; Disease Models, Animal; Dopamine; Homovanil

2001